December 21, 2015
UCB Taps Sinequa to Speed Up, Reduce Costs of Clinical Trial Data Searchers
By Steve Anderson
Data is great to have, but if it can't be used, its value falls through the floor. It's an axiom increasingly on par with “measure twice, cut once,” , and UCB is demonstrating this clearly with a new connection to Sinequa that should reduce the cost of searching for key points of clinical trial data.
More specifically, UCB turned to the Sinequa Big Data Search & Analytics Platform as a means to ramp up search functions and reduce the costs involved in spending a lot of time hunting for data. With the Sinequa system, UCB can more rapidly find relevant data sets from earlier trials, and help answer questions that crop up as part of regular drug development. That makes new development proceed more rapidly, and get more product out into the market, satisfying patient demand for more effective pharmaceuticals.
UCB has a particular call for such improved speeds in searching, as the company counts over 8,500 employees to its credit worldwide. That's a lot of information being generated, and since the company's focus is on developing therapies to address particularly serious diseases, it's a market that requires speed. In just the last 15 years, the company has generated over 10 million files that occasionally require searching, and that 10 million covers around 20 terabytes of data. Worse, the quantity grows at about 30 percent a year.
With Sinequa, UCB can find relevant data more rapidly, meaning less time to process requests and return information, and less waiting for information. That takes some waste out of the system, as no one need to “find something else to do” while waiting for data, and fewer processes need to be interrupted. Sinequa's system combines natural language processing and data indexing that can be both structured and unstructured to produce powerful new search measures. Some big names in the field already turn to Sinequa, including AstraZeneca, Biogen, and Siemens (News - Alert).
UCB is quite pleased with its new tools so far—its senior manager of global IT in drug development Oliver Thoennessen called Sinequa's tools “simply great technology”, a point assented throughout the organization—and with good reason. Time savings can be one of the most underrated savings sources there is; no one bats an eye at saving 30 seconds on one transaction, but when it's something that's done hundreds of times a day across an organization, pretty soon the time savings is equivalent to having hired a whole other person without raising payroll.
Better data searches mean time saved, and that represents huge potential savings overall. Faster time to market, more development, and a better reputation in the market can all come about from tools like Sinequa's, and that makes faster data searches a valuable addition to UCB's lineup.
Edited by Kyle Piscioniere